168 related articles for article (PubMed ID: 24677604)
1. D-cycloserine for treating anxiety disorders: making good exposures better and bad exposures worse.
Hofmann SG
Depress Anxiety; 2014 Mar; 31(3):175-7. PubMed ID: 24677604
[No Abstract] [Full Text] [Related]
2. Lessons learned from D-cycloserine: the promise and limits of drug facilitation of exposure therapy.
Rodebaugh TL; Lenze EJ
J Clin Psychiatry; 2013 Apr; 74(4):415-6. PubMed ID: 23656850
[No Abstract] [Full Text] [Related]
3. D-cycloserine nasal formulation development for anxiety disorders by using polymeric gels.
Shin Y; Kokate R; Desai V; Bhushan A; Kaushal G
Drug Discov Ther; 2018; 12(3):142-153. PubMed ID: 29998995
[TBL] [Abstract][Full Text] [Related]
4. Learn to forget: Does post-exposure administration of d-cycloserine enhance fear extinction in agoraphobia?
Pyrkosch L; Mumm J; Alt I; Fehm L; Fydrich T; Plag J; Ströhle A
J Psychiatr Res; 2018 Oct; 105():153-163. PubMed ID: 30237105
[TBL] [Abstract][Full Text] [Related]
5. Changes in Dosing and Dose Timing of D-Cycloserine Explain Its Apparent Declining Efficacy for Augmenting Exposure Therapy for Anxiety-related Disorders: An Individual Participant-data Meta-analysis.
Rosenfield D; Smits JAJ; Hofmann SG; Mataix-Cols D; de la Cruz LF; Andersson E; Rück C; Monzani B; Pérez-Vigil A; Frumento P; Davis M; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner CA; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P; Turner C; Otto MW
J Anxiety Disord; 2019 Dec; 68():102149. PubMed ID: 31698111
[TBL] [Abstract][Full Text] [Related]
6. Critical parameters for D-cycloserine enhancement of cognitive-behaviorial therapy for obsessive-compulsive disorder.
Rothbaum BO
Am J Psychiatry; 2008 Mar; 165(3):293-6. PubMed ID: 18316423
[No Abstract] [Full Text] [Related]
7. D-Cycloserine Augmentation of Exposure-Based Cognitive Behavior Therapy for Anxiety, Obsessive-Compulsive, and Posttraumatic Stress Disorders: A Systematic Review and Meta-analysis of Individual Participant Data.
Mataix-Cols D; Fernández de la Cruz L; Monzani B; Rosenfield D; Andersson E; Pérez-Vigil A; Frumento P; de Kleine RA; Difede J; Dunlop BW; Farrell LJ; Geller D; Gerardi M; Guastella AJ; Hofmann SG; Hendriks GJ; Kushner MG; Lee FS; Lenze EJ; Levinson CA; McConnell H; Otto MW; Plag J; Pollack MH; Ressler KJ; Rodebaugh TL; Rothbaum BO; Scheeringa MS; Siewert-Siegmund A; Smits JAJ; Storch EA; Ströhle A; Tart CD; Tolin DF; van Minnen A; Waters AM; Weems CF; Wilhelm S; Wyka K; Davis M; Rück C; ; Altemus M; Anderson P; Cukor J; Finck C; Geffken GR; Golfels F; Goodman WK; Gutner C; Heyman I; Jovanovic T; Lewin AB; McNamara JP; Murphy TK; Norrholm S; Thuras P
JAMA Psychiatry; 2017 May; 74(5):501-510. PubMed ID: 28122091
[TBL] [Abstract][Full Text] [Related]
8. Opposing effects of D-cycloserine on fear despite a common extinction duration: interactions between brain regions and behavior.
Bolkan SS; Lattal KM
Neurobiol Learn Mem; 2014 Sep; 113():25-34. PubMed ID: 24374132
[TBL] [Abstract][Full Text] [Related]
9. D-cycloserine as an augmentation strategy for cognitive behavioral therapy for anxiety disorders: an update.
Hofmann SG; Sawyer AT; Asnaani A
Curr Pharm Des; 2012; 18(35):5659-62. PubMed ID: 22632472
[TBL] [Abstract][Full Text] [Related]
10. A meta-analysis of D-cycloserine and the facilitation of fear extinction and exposure therapy.
Norberg MM; Krystal JH; Tolin DF
Biol Psychiatry; 2008 Jun; 63(12):1118-26. PubMed ID: 18313643
[TBL] [Abstract][Full Text] [Related]
11. Enhancing prolonged exposure therapy for posttraumatic stress disorder with D-cycloserine: further support for treatments that promote experience-dependent neuroplasticity.
Krystal JH
Biol Psychiatry; 2012 Jun; 71(11):932-4. PubMed ID: 22579302
[No Abstract] [Full Text] [Related]
12. Augmentation of exposure therapy with D-cycloserine for social anxiety disorder.
Hofmann SG; Meuret AE; Smits JA; Simon NM; Pollack MH; Eisenmenger K; Shiekh M; Otto MW
Arch Gen Psychiatry; 2006 Mar; 63(3):298-304. PubMed ID: 16520435
[TBL] [Abstract][Full Text] [Related]
13. Dose Timing of D-Cycloserine to Augment Exposure Therapy for Social Anxiety Disorder: A Randomized Clinical Trial.
Smits JAJ; Pollack MH; Rosenfield D; Otto MW; Dowd S; Carpenter J; Dutcher CD; Lewis EM; Witcraft SM; Papini S; Curtiss J; Andrews L; Kind S; Conroy K; Hofmann SG
JAMA Netw Open; 2020 Jun; 3(6):e206777. PubMed ID: 32496566
[TBL] [Abstract][Full Text] [Related]
14. Augmentation of behavior therapy with D-cycloserine for obsessive-compulsive disorder.
Wilhelm S; Buhlmann U; Tolin DF; Meunier SA; Pearlson GD; Reese HE; Cannistraro P; Jenike MA; Rauch SL
Am J Psychiatry; 2008 Mar; 165(3):335-41; quiz 409. PubMed ID: 18245177
[TBL] [Abstract][Full Text] [Related]
15. D-cycloserine augmentation of behavior therapy for anxiety and obsessive-compulsive disorders: A meta-analysis.
Bürkner PC; Bittner N; Holling H; Buhlmann U
PLoS One; 2017; 12(3):e0173660. PubMed ID: 28282427
[TBL] [Abstract][Full Text] [Related]
16. D-Cycloserine lowers kynurenic acid formation--new mechanism of action.
Baran H; Kepplinger B
Eur Neuropsychopharmacol; 2014 Apr; 24(4):639-44. PubMed ID: 24189377
[TBL] [Abstract][Full Text] [Related]
17. A randomized placebo-controlled trial of D-cycloserine to enhance exposure therapy for posttraumatic stress disorder.
de Kleine RA; Hendriks GJ; Kusters WJ; Broekman TG; van Minnen A
Biol Psychiatry; 2012 Jun; 71(11):962-8. PubMed ID: 22480663
[TBL] [Abstract][Full Text] [Related]
18. Pharmacological enhancement of behavioral therapy: focus on posttraumatic stress disorder.
Choi DC; Rothbaum BO; Gerardi M; Ressler KJ
Curr Top Behav Neurosci; 2010; 2():279-99. PubMed ID: 21309114
[TBL] [Abstract][Full Text] [Related]
19. Neurocognitive processes in d-cycloserine augmented single-session exposure therapy for anxiety: A randomized placebo-controlled trial.
Reinecke A; Nickless A; Browning M; Harmer CJ
Behav Res Ther; 2020 Jun; 129():103607. PubMed ID: 32229324
[TBL] [Abstract][Full Text] [Related]
20. d-Cycloserine does not enhance the effects of in vivo exposure among young people with broad-based anxiety disorders.
Rapee RM; Jones MP; Hudson JL; Malhi GS; Lyneham HJ; Schneider SC
Behav Res Ther; 2016 Dec; 87():225-231. PubMed ID: 27771572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
